Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

84
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
84
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

126
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
126
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

68
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
68

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Old may still be gold: 45- to 55-year-old donors yield safe early outcomes in adult heart transplantation.

JTCVS open·2026
Same author

Intraoperative Surface Echocardiography for Donor Heart Assessment During Normothermic Regional Perfusion.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Review of Interventional Options and Surgical Techniques in the Management of Acute Pulmonary Embolism.

The Journal of surgical research·2026
Same author

Real-time cardiac power output index predicts imminent need for extracorporeal membrane oxygenation after heart transplantation.

JHLT open·2026
Same author

Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin: A Randomized Controlled Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Ethical Considerations for Heart Organ Allocation: Current Landscape and Future Policy Guidance: A Scientific Statement From the American Heart Association.

Circulation·2026

Related Experiment Video

Updated: Nov 26, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.7K

Disposable Component Selection in Extracorporeal Life Support: A Cost Analysis.

John W Stokes1, Whitney D Gannon2, Yuliya Tipograf3

  • 1From the Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|December 14, 2020
PubMed
Summary

Developing a cost analysis tool for extracorporeal life support (ECLS) disposables can help programs reduce expenses. This analysis forecasts costs based on device selection, case volume, and device mix over five years.

More Related Videos

Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

1.9K
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

1.1K

Related Experiment Videos

Last Updated: Nov 26, 2025

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.7K
Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

1.9K
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

1.1K

Area of Science:

  • Critical Care Medicine
  • Health Economics
  • Medical Technology Assessment

Background:

  • Extracorporeal life support (ECLS) is a vital but resource-intensive treatment.
  • Disposable components represent a significant and modifiable cost factor in ECLS.
  • Effective cost-conscious device selection requires robust financial analysis tools.

Purpose of the Study:

  • To develop and demonstrate a disposable cost analysis tool for ECLS programs.
  • To forecast estimated costs associated with ECLS device disposables over a 5-year period.
  • To inform cost-saving strategies through informed device selection.

Main Methods:

  • Generated a disposable cost analysis incorporating an assumption table, net present value (NPV), and sensitivity analysis.
  • Modeled costs over 5 years using varying case volumes and device mixes.
  • Included four distinct device options with specified cost and utilization assumptions.

Main Results:

  • The 5-year unadjusted and NPV costs for a sample scenario were $3,691,000 and $2,765,000, respectively.
  • Sensitivity analysis revealed significant cost variations based on device mix, with NPVs ranging from $1,246,000 to $6,644,000.
  • Model B (100% Device 1) had the lowest NPV, while Model F (75% Device 3, 25% Device 4) had the highest.

Conclusions:

  • The developed disposable cost analysis tool can effectively forecast ECLS program expenses.
  • Strategic device selection and mix optimization are crucial for reducing ECLS programmatic costs.
  • ECLS programs can leverage this tool to make financially informed decisions and enhance resource management.